Elizabeth Arden, Inc. (NASDAQ:RDEN)

rexlove (99.11) Submitted: 2/6/2012 10:39:18 PM : Start Price: $38.00 RDEN Score: +0.75

low peg

Ironbob (73.15) Submitted: 12/16/2011 5:38:58 PM : Start Price: $25.75 RDEN Score: +44.45

I'll pay just to watch that Red Door commercial over and over.

svannuffel (90.63) Submitted: 12/5/2011 11:19:35 AM : Start Price: $36.39 RDEN Score: -0.65

Lipstick index !

morriss003 (35.31) Submitted: 1/14/2011 2:48:21 PM : Start Price: $24.41 RDEN Score: +53.03

It gets a lot of its revenue from China and is likely to increase revenue.

ElleRB (78.54) Submitted: 2/9/2010 3:20:26 PM : Start Price: $17.11 RDEN Score: -99.23

It seems to me that Elizabeth Arden is creeping downhill. During a recent visit to one of the spas, I was disappointed by chintzy materials, cheap products, and sub-par service. Without real elegance, luxury, or quality, I worry that the company will lost the cache necessary to keep this stock on an upward swing.

tenmiles (99.96) Submitted: 1/15/2010 10:54:27 AM : Start Price: $16.30 RDEN Score: -117.10

Not that cosmetically appealing at 26x forward earnings - selling off the Bare Essentials buzz

NotJesseL (< 20) Submitted: 1/18/2009 8:26:38 PM : Start Price: $6.71 RDEN Score: -409.05

There is a bullish story to this stock - lipstick sales go up during a depression/recession. but its PE is way too high, too much debt, Revenue is increasing but net income is negative and decreasing. What seems to me like a classic - "We lose 3 cents on each unit but we make it up in volume" story.

springfieldcolor (75.69) Submitted: 1/17/2009 9:47:06 PM : Start Price: $6.71 RDEN Score: +409.05

38% dip..will atleast expect it to go 5-10% north in coming weeks

yellowsmurf27 (52.92) Submitted: 5/29/2008 2:27:22 PM : Start Price: $15.76 RDEN Score: +144.22

The type of stock helps me to believe that this will outperform it's competitors.

LilBoo000 (< 20) Submitted: 5/2/2008 9:49:20 AM : Start Price: $13.99 RDEN Score: +175.84

The stock still has solid fundamentals and a strong customer base. I think it is oversold and a good buy at this price.

JohnStuartMill1 (57.52) Submitted: 3/12/2008 9:12:29 AM : Start Price: $18.22 RDEN Score: +104.93

Low PEG. Stock will rise to the market.

GabeCaps (89.52) Submitted: 2/5/2007 12:22:38 PM : Start Price: $20.98 RDEN Score: +84.13

They've had a bad year, and have been beaten up by acquisition troubles. I think they're ready for new heights.

NetscribeConsGds (93.99) Submitted: 1/22/2007 6:51:46 AM : Start Price: $17.89 RDEN Score: -114.63

Smell a rat on Elizabeth Arden. It is an US based beauty products company engaged in the manufacturing and marketing of fragrances, skin care products and cosmetic products worldwide. In addition to over 100 owned and licensed prestige brands, the company also distributes over 200 additional prestige fragrance brands principally to mass retailers in the United States. Fragrances contribute around 75% of the sales followed by skincare and cosmetics.

The life cycle of fragrances has shortened dramatically in recent years. Loyalty towards the brand is declining and more and more customers are experimenting with different brands within a short span. Hence, companies are launching new products at a very faster rate to meet the market demand. To face the industry challenges, Elizabeth Arden has been incurring huge marketing spends and undergoing promotional activities, which is finally grinding down the bottom lines of the company. The company did generate about 12% rise in revenues in the first quarter of fiscal 2007 driven by sale of new brands and acquisitions of Riviera and Sovereign. However, revenues are rising at the cost of spiraling expenses. In the past two quarters, the company financials has gone in the red and costs are likely to rise ahead on account of marketing expenses and acquisition related integration costs.

Conversely, management is upbeat on their ‘Prevage’ skin care line as demand for anti-aging products is rising. However on the negative side, revenues could take a hit due to Wal-Mart’s shift in the product mix, as Elizabeth Arden currently derives significant revenues from Wal-Mart. Also, it is expecting the benefit of acquisitions to materialize later in 2008. Considering these facts, the scrip does not look an exciting investment from one-year perspective.

schubper (55.56) Submitted: 11/16/2006 8:30:04 PM : Start Price: $18.40 RDEN Score: +106.46

Undervalued take-over candidate

MCKInathan (97.71) Submitted: 11/5/2006 11:04:17 PM : Start Price: $18.38 RDEN Score: +104.48

Price is right to buy. Holiday season should boost sales of beauty products and I like the company's management.